New drug approvals to watch out for in 2015
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration approved more new molecular entities in 2014 than it had done in any year since 19961, but what should we expect for 2015? Here Scrip Intelligence takes a look at ten of the more interesting new products that are set for approval in the US and/or the EU over the coming 12 months.